GLG Partners’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

GLG Partners’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-327,116	Closed	-$13.5M	–	583
2015 Q2	$13.5M	Buy	+327,116	New	+$11.7M	0.35%	83

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

GLG Partners's BRLI Position: Q3 2015 in Review

GLG Partners sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 327,116 shares — an estimated $13.5M sold.

GLG Partners first reported a position in BRLI in Q2 2015 and held it in 1 quarter. The position peaked at $13.5M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

GLG Partners reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
GLG Partners sold 327,116 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $13.5M.
GLG Partners first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2015 and held it in 1 quarter.
GLG Partners's BIO-REFERENCE LABS INC-NEW- position peaked at $13.5M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on GLG Partners's 13F filing for Q3 2015, filed 16 Nov 2015.